Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer
Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer
About this item
Full title
Author / Creator
Li, Jingjie , Qin, Zuoshu , Li, Yunqi , Huang, Baozhu , Xiao, Qimeng , Chen, Peiqin , Luo, Yifan , Zheng, Wenxin , Zhang, Tao and Zhang, Zhenbo
Publisher
Germany: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Germany: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
The progestin regimen is one of the main therapeutic strategies for women with endometrial cancer who undergo conservative management. Although many patients respond well to initial therapy, progestin‐refractory disease inevitably emerges, and the molecular basis underlying progestin resistance has not been comprehensively elucidated. Herein, they...
Alternative Titles
Full title
Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e1882ba92ef7494fac6c6ee35030432d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e1882ba92ef7494fac6c6ee35030432d
Other Identifiers
ISSN
2198-3844
E-ISSN
2198-3844
DOI
10.1002/advs.202310208
